Suppr超能文献

经尿道注射肉毒毒素 A 可显著降低创伤性脊髓损伤患者的尿路感染发生率。

Detrusor botulinum toxin A injection significantly decreased urinary tract infection in patients with traumatic spinal cord injury.

机构信息

Department of Urology, China Rehabilitation Research Center, Beijing, China.

出版信息

Spinal Cord. 2013 Jun;51(6):487-90. doi: 10.1038/sc.2012.180. Epub 2013 Jan 29.

Abstract

STUDY DESIGN

The study was designed as a single-arm clinical trial.

OBJECTIVES

To investigate the effect of detrusor botulinum toxin A (BoNTA) injection on urinary tract infection (UTI) in patients with spinal cord injury (SCI).

SETTING

The study was performed in a national rehabilitation research center of China.

METHODS

Between September 2010 and May 2012, 41 male inpatients with neurogenic detrusor overactivity (NDO) caused by traumatic SCI, mean age 36.0±8.8 years, duration of SCI since inclusion 21.5±17.3 months, received an injection of 300 U BoNTA into detrusor. Before and 3 months after injection, each patient kept a bladder diary, underwent video-urodynamic investigation and urine culture. All UTIs occurring in the 6 months before and the 6 months after injection were recorded.

RESULTS

Before injection, the mean number of UTI over 6 months was 1.39±1.36. After injection, the mean significantly decreased to 0.78±0.96 (P=0.023). The mean maximum detrusor pressure during filling decreased significantly in the patients of detrusor overactivity (n=24) compared with patients of normo-active detrusor (n=17) after injection (35.4±12.2 vs 20.9±7.9 cmH(2)O, P=0.000), meantime, the decrease of UTI was significant in the former (1.29±1.21 vs 0.41±0.62 cmH(2)O, P=0.015) while no significant in the latter (1.46±1.47 vs 1.04±1.08, P=0.319).

CONCLUSION

Detrusor BoNTA injection significantly decreased UTI in SCI patients with NDO. This effect seems to be related to the decrease of detrusor pressure.

摘要

研究设计

本研究设计为单臂临床试验。

目的

探讨逼尿肌肉毒毒素 A(BoNTA)注射对脊髓损伤(SCI)患者尿路感染(UTI)的影响。

地点

本研究在中国的一家国家康复研究中心进行。

方法

2010 年 9 月至 2012 年 5 月,41 名男性 SCI 患者因神经源性逼尿肌过度活动(NDO)住院,平均年龄 36.0±8.8 岁,纳入后 SCI 持续时间 21.5±17.3 个月,将 300U BoNTA 注入逼尿肌。在注射前和注射后 3 个月,每位患者均保留膀胱日记,行视频尿动力学检查和尿液培养。记录注射前 6 个月和注射后 6 个月内发生的所有 UTI。

结果

注射前,6 个月 UTI 平均发生 1.39±1.36 次。注射后,平均显著减少至 0.78±0.96(P=0.023)。逼尿肌过度活动患者(n=24)注射后最大逼尿肌压力在充盈期明显低于正常逼尿肌患者(n=17)(35.4±12.2 对 20.9±7.9cmH2O,P=0.000),同时,前者 UTI 减少明显(1.29±1.21 对 0.41±0.62cmH2O,P=0.015),而后者无明显变化(1.46±1.47 对 1.04±1.08,P=0.319)。

结论

逼尿肌 BoNTA 注射可显著降低 SCI 合并 NDO 患者的 UTI。这种效果似乎与逼尿肌压力降低有关。

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验